Cargando…

Upregulation of HCFC1 expression promoted hepatocellular carcinoma progression through inhibiting cell cycle arrest and correlated with immune infiltration

Background: Host cell factor 1 (HCFC1) was reported associated with the progression of a variety of cancers. However, its role in the prognosis and immunological characteristics of hepatocellular carcinoma (HCC) patients has not been revealed. Methods: The expression and prognostic value of HCFC1 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huaxiang, Yu, Meng, Yang, Chengkai, Li, Qingsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240668/ https://www.ncbi.nlm.nih.gov/pubmed/37283799 http://dx.doi.org/10.7150/jca.84579

Ejemplares similares

High MCM8 expression correlates with unfavorable prognosis and induces immune cell infiltration in hepatocellular carcinoma
por: Yu, Meng, et al.
Publicado: (2022)

Exposure Assessment for Toxic Hepatitis Caused by HCFC-123
por: Kim, Ki-Woong, et al.
Publicado: (2018)

SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma
por: Lin, Jing, et al.
Publicado: (2023)

PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest
por: Wang, Xuyang, et al.
Publicado: (2023)

Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy
por: Chern, Tiffany, et al.
Publicado: (2022)

Acute liver failure caused by occupational exposure to HCFC-123: Two case reports
por: Choe, Hun Jee, et al.
Publicado: (2019)

Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma
por: Zhang, Youfu, et al.
Publicado: (2022)

Hcfc1a regulates neural precursor proliferation and asxl1 expression in the developing brain
por: Castro, Victoria L., et al.
Publicado: (2020)

Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
por: Wu, Qiong, et al.
Publicado: (2010)

Bioinformatics analysis and experimental validation of a novel autophagy-related signature relevant to immune infiltration for recurrence prediction after curative hepatectomy
por: Wang, Huaxiang, et al.
Publicado: (2023)

Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Evaluation of the genotoxicity potential and chronic inhalation toxicity of 1,1-dichloro-1-fluoroethane (HCFC-141 b)()()
por: Millischer, R.-J., et al.
Publicado: (1995)

HCFC1 variants in the proteolysis domain are associated with X‐linked idiopathic partial epilepsy: Exploring the underlying mechanism
por: He, Na, et al.
Publicado: (2023)

HCFC-123-induced toxic hepatitis and death at a Korean fire extinguisher manufacturing facility: a case series
por: Shin, Mu Young, et al.
Publicado: (2018)

HCFC2 is needed for IRF1- and IRF2-dependent Tlr3 transcription and for survival during viral infections
por: Sun, Lei, et al.
Publicado: (2017)

High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma
por: Xiu, Mengxi, et al.
Publicado: (2023)

Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Ying, et al.
Publicado: (2023)

COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma
por: Fang, Weidan, et al.
Publicado: (2022)

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration
por: Liu, Xin, et al.
Publicado: (2021)

Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

Upregulation of Biomarker Limd1 Was Correlated with Immune Infiltration in Doxorubicin-Related Cardiotoxicity
por: Zhang, Rui, et al.
Publicado: (2023)

SQSTM1/p62 regulate breast cancer progression and metastasis by inducing cell cycle arrest and regulating immune cell infiltration
por: Qi, Jia-Long, et al.
Publicado: (2021)

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration
por: Wang, Song, et al.
Publicado: (2022)

NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021)

Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer
por: He, Lingling, et al.
Publicado: (2022)

Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest
por: Oura, Kyoko, et al.
Publicado: (2017)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma
por: Xu, Jun Hui, et al.
Publicado: (2021)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021)

ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression
por: Deng, Yuanfei, et al.
Publicado: (2022)

Methyl-Cantharidimide Inhibits Growth of Human Hepatocellular Carcinoma Cells by Inducing Cell Cycle Arrest and Promoting Apoptosis
por: Huang, Xiangzhong, et al.
Publicado: (2019)

Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma
por: Yang, Chengkai, et al.
Publicado: (2023)

Knockdown of cyclooxygenase-2 leads to growth inhibition and cell cycle arrest in hepatocellular carcinoma cells
por: Lv, Xiuhe, et al.
Publicado: (2019)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nls1kuvirueupbbv23bgpe97hb